Pharmaceuticals & Biotech Norwegian Community
Our community narratives are driven by numbers and valuation.
Pharmaceuticals & Biotech Norwegian Investing Ideas
Precision Medicine Will Continue Advancing Through Biomanufacturing And Gene Therapies
Key Takeaways Strong biomanufacturing growth and broader revenue streams are fueled by robust product adoption and expansion into new advanced therapeutics markets. Enhanced commercial execution, geographic reach, and operational scalability position the company for stable, long-term, high-margin revenue growth.Read more
66
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
NOK 32
25.9% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
20.42% p.a.
Profit Margin
30.92%
Future PE
33.1x
Price in 2029
NOK 38.49
Adoption Of ForTec’s Mobile Strategy Will Increase Market Penetration In The US
Key Takeaways Expanding blue light cystoscopy in Europe and the U.S. through strategic initiatives is expected to enhance market access and drive revenue growth. Success in partnerships and technology launches is likely to fuel growth, while regulatory reclassification and approvals could unlock new revenue streams.Read more
68
users have viewed this narrative1users have liked this narrative
0users have commented on this narrative
8users have followed this narrative
AN
NOK 82.5
4.7% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
7.69% p.a.
Profit Margin
9.6%
Future PE
38.61x
Price in 2028
NOK 97.35
